Skip to main content
Be The Investor
BTI Market Newsstocks
Back to News

Kimberly-Clark's Yield Looks Attractive, but Cash Coverage Is Tight

Kimberly-Clark's Yield Looks Attractive, but Cash Coverage Is Tight

Kimberly-Clark's dividend yield is near 5%, below a widely cited 5.5% figure but still elevated. Thin free-cash-flow coverage, heavy investment and the proposed Kenvue acquisition complicate the income case.

Kimberly-Clark has become a tempting income stock after a steep decline, but the headline yield needs a correction and the cash coverage deserves more attention than the label "Dividend King." At a quarterly dividend of $1.28 and a share price near $107, the annualized yield is about 4.8%, not 5.5%. The yield would reach roughly 5.2% at a price near $98.

A near-5% yield is still high for the maker of Huggies, Kleenex and Cottonelle. The company has increased its dividend for more than 50 consecutive years, which signals a strong commitment to shareholders. It does not make the payment automatically safe under every capital-allocation scenario.

In 2025, Kimberly-Clark generated about $1.64 billion of free cash flow and paid roughly $1.66 billion in dividends. That means the dividend used slightly more than the year's free cash flow. Capital expenditures rose to $1.14 billion from $721 million in 2024, so the coverage pressure partly reflects elevated investment rather than a collapse in operating cash generation.

Loading market context

The first half of 2026 showed a similar constraint. Free cash flow was $877 million, while dividend payments consumed about 96% of that amount. The company ended the second quarter with $956 million of cash and $6.52 billion of debt. Those figures do not indicate an immediate liquidity crisis, but they leave less room for setbacks or aggressive shareholder returns.

Operating results are also mixed. Second-quarter revenue was $4.19 billion, and management said misinformation in China reduced organic sales growth by about half a percentage point. Kimberly-Clark expected adjusted earnings per share to decline at a low-single-digit rate for 2026.

The proposed acquisition of Kenvue adds another layer. The companies announced a transaction with an enterprise value of about $48.7 billion, intended to create a larger consumer-health and personal-care group. If completed, the deal may broaden the portfolio, but integration, financing and execution will compete for management attention and cash.

The investment case is therefore not simply yield versus no yield. Kimberly-Clark offers durable brands and a long dividend record, but current cash generation covers the payout narrowly. Investors should watch whether capital spending normalizes, free cash flow improves and the Kenvue transaction preserves balance-sheet flexibility.

Continue your KVUE research